Matrix Capital Reports a $108 Million ZNTL Buy

JC Parets
June 21, 2023

The most significant transaction on today's list comes in a Form 4 filing by Matrix Capital Management.

The hedge fund reported the acquisition of 4,760,000 shares, equivalent to $107.8 million, in the small-cap biotech company Zentalis Pharmaceuticals, Inc $ZNTL.

Matrix Capital now owns 19.81% of ZNTL.

Here’s The Hot List, with data through June 20, 2023:

The only 13D on today’s list was filed by Access Industries Holdings LLC, which revealed an initial stake of 14.95% in Disc Medicine Inc $IRON.

In another Form 4, the CEO of Nerdy Inc $NRDY revealed  a small purchase.

In the options market, there was bullish flow in Las Vegas Sands Corp $LVS.

Stay tuned. We'll be back on Thursday with more insider activity.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team

Filed Under: